ReviewFrontiers in immunology2026

PSMA-directed CAR-T cell therapy for metastatic castration-resistant prostate cancer: a next-generation engineering perspective on stem cell-derived immune effectors.

Meng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.